Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Saito, H.
Right arrow Articles by Bodey, G. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Saito, H.
Right arrow Articles by Bodey, G. P.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of Antimicrobial Chemotherapy (1987) 20, 497-503
© 1987 The British Society for Antimicrobial Chemotherapy


research-article

In-vitro activity of LY146032 against Gram-positive isolates from cancer patients

Hiroshi Saito, Kenneth V. I. Rolston*, Dah Hsi Ho, Barbara LeBlanc and Gerald P. Bodey

Section of Infectious Diseases, Department of Medical Specialties. The University of Texas M. D. Anderson Hospital and Tumor Institute 1515 Holcombe Boulevard, Houston, Texas 77030. U.S.A.

accepted 1 April 1987


*Correspondence to: Kenneth V. I. Rolston, Infectious Diseases—47, M. D. Anderson Hospital, 6723 Bertner Avenue, Houston, Texas 77030, U.S.A.

The in-vitro activity of LY146032 was compared with that of other antibiotics against Gram-positive organisms, mostly isolated from cancer patients. LY 146032 inhibited all isolates, including methicillin-resistant Staphylococcus aureus and Streptococcus faecalis, at a concentration of ≤2.0 mg/l. The MBCs of this new drug were within eight times the MICs for all bacteria tested.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.